IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 68 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143,375 | +22.7% | 2,763 | +42.0% | 0.00% | – |
| Q2 2023 | $116,890 | +215.7% | 1,946 | +159.8% | 0.00% | – |
| Q1 2023 | $37,024 | -9.7% | 749 | +2.7% | 0.00% | – |
| Q4 2022 | $41,000 | +24.2% | 729 | +1.5% | 0.00% | – |
| Q3 2022 | $33,000 | +57.1% | 718 | +22.9% | 0.00% | – |
| Q2 2022 | $21,000 | +23.5% | 584 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | +240.0% | 584 | +305.6% | 0.00% | – |
| Q4 2021 | $5,000 | +25.0% | 144 | +17.1% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 123 | -4.7% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 129 | +5.7% | 0.00% | – |
| Q1 2021 | $5,000 | – | 122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $29,942,304 | 35.70% |
| RTW INVESTMENTS, LP | 6,096,387 | $316,402,485 | 6.68% |
| Paradigm Biocapital Advisors LP | 1,384,686 | $71,865,203 | 4.88% |
| Rock Springs Capital Management LP | 2,943,710 | $152,778,549 | 4.09% |
| Logos Global Management LP | 450,000 | $23,355,000 | 3.12% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $21,050,640 | 2.97% |
| GREAT POINT PARTNERS LLC | 290,917 | $15,098,592 | 2.75% |
| Nicholas Investment Partners, LP | 512,855 | $26,617,175 | 1.99% |
| Eschler Asset Management LLP | 30,000 | $1,557,000 | 1.82% |
| COWEN AND COMPANY, LLC | 460,036 | $23,875,868 | 1.67% |